Does the media refer more to ASTH or APLD?

In the previous week, Applied Digital had 15 more articles in the media than Astrana Health. MarketBeat recorded 19 mentions for Applied Digital and 4 mentions for Astrana Health. Astrana Health's average media sentiment score of 0.63 beat Applied Digital's score of 0.58 indicating that Astrana Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Astrana Health 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Applied Digital 8 Very Positive mention(s) 4 Positive mention(s) 4 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation & earnings, QBTS or ASTH?

Astrana Health has higher revenue and earnings than D-Wave Quantum. D-Wave Quantum is trading at a lower price-to-earnings ratio than Astrana Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio D-Wave Quantum $24.59M 280.72 -$355.06M -$1.13 N/A Astrana Health $3.18B 0.83 $22.49M $0.61 78.10

Does the media prefer QBTS or ASTH?

In the previous week, D-Wave Quantum had 22 more articles in the media than Astrana Health. MarketBeat recorded 26 mentions for D-Wave Quantum and 4 mentions for Astrana Health. Astrana Health's average media sentiment score of 0.63 beat D-Wave Quantum's score of 0.61 indicating that Astrana Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment D-Wave Quantum 9 Very Positive mention(s) 9 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Astrana Health 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer HQY or ASTH?

In the previous week, HealthEquity had 3 more articles in the media than Astrana Health. MarketBeat recorded 7 mentions for HealthEquity and 4 mentions for Astrana Health. HealthEquity's average media sentiment score of 0.82 beat Astrana Health's score of 0.63 indicating that HealthEquity is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HealthEquity 4 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Astrana Health 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings and valuation, ASTH or STN?

Stantec has higher revenue and earnings than Astrana Health. Stantec is trading at a lower price-to-earnings ratio than Astrana Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Astrana Health $3.18B 0.83 $22.49M $0.61 78.10 Stantec $5.83B 1.34 $343.11M $3.12 22.06

Does the media refer more to ASTH or STN?

In the previous week, Astrana Health had 1 more articles in the media than Stantec. MarketBeat recorded 4 mentions for Astrana Health and 3 mentions for Stantec. Stantec's average media sentiment score of 1.10 beat Astrana Health's score of 0.63 indicating that Stantec is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Astrana Health 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Stantec 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor ASTH or Z?

In the previous week, Zillow Group had 30 more articles in the media than Astrana Health. MarketBeat recorded 34 mentions for Zillow Group and 4 mentions for Astrana Health. Astrana Health's average media sentiment score of 0.63 beat Zillow Group's score of 0.16 indicating that Astrana Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Astrana Health 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Zillow Group 4 Very Positive mention(s) 2 Positive mention(s) 23 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral

Astrana Health (ASTH) Competitors

$47.64 +0.76 (+1.62%)

Closing price 07/13/2026 04:00 PM Eastern

Extended Trading

$47.75 +0.11 (+0.23%)

As of 07/13/2026 07:23 PM Eastern

Compare

ASTH vs. APLD, QBTS, HQY, STN, and Z

Should you buy Astrana Health stock or one of its competitors? MarketBeat compares Astrana Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Astrana Health include Applied Digital (APLD), D-Wave Quantum (QBTS), HealthEquity (HQY), Stantec (STN), and Zillow Group (Z). These companies are all part of the "business services" industry.

How does Astrana Health compare to Applied Digital?

Astrana Health (NASDAQ:ASTH) and Applied Digital (NASDAQ:APLD) are both mid-cap business services companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership, earnings and profitability.

In the previous week, Applied Digital had 15 more articles in the media than Astrana Health. MarketBeat recorded 19 mentions for Applied Digital and 4 mentions for Astrana Health. Astrana Health's average media sentiment score of 0.63 beat Applied Digital's score of 0.58 indicating that Astrana Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Astrana Health	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Applied Digital	8 Very Positive mention(s)	4 Positive mention(s)	4 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Astrana Health has a net margin of 0.86% compared to Applied Digital's net margin of -52.84%. Astrana Health's return on equity of 9.22% beat Applied Digital's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Astrana Health	0.86%	9.22%	3.54%
Applied Digital	-52.84%	-15.91%	-4.62%

Astrana Health has a beta of 0.89, meaning that its stock price is 11% less volatile than the broader market. Comparatively, Applied Digital has a beta of 5.67, meaning that its stock price is 467% more volatile than the broader market.

Astrana Health currently has a consensus price target of $45.00, suggesting a potential downside of 5.54%. Applied Digital has a consensus price target of $70.56, suggesting a potential upside of 144.64%. Given Applied Digital's stronger consensus rating and higher possible upside, analysts plainly believe Applied Digital is more favorable than Astrana Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Astrana Health	0 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.78
Applied Digital	2 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	3 Strong Buy rating(s)	2.94

52.8% of Astrana Health shares are held by institutional investors. Comparatively, 65.7% of Applied Digital shares are held by institutional investors. 20.3% of Astrana Health shares are held by company insiders. Comparatively, 9.5% of Applied Digital shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Astrana Health has higher revenue and earnings than Applied Digital. Applied Digital is trading at a lower price-to-earnings ratio than Astrana Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Astrana Health	$3.18B	0.83	$22.49M	$0.61	78.10
Applied Digital	$144.19M	57.16	-$231.07M	-$0.74	N/A

Summary

Astrana Health beats Applied Digital on 9 of the 17 factors compared between the two stocks.

How does Astrana Health compare to D-Wave Quantum?

D-Wave Quantum (NYSE:QBTS) and Astrana Health (NASDAQ:ASTH) are both mid-cap business services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, institutional ownership, dividends, profitability, media sentiment, analyst recommendations, earnings and valuation.

In the previous week, D-Wave Quantum had 22 more articles in the media than Astrana Health. MarketBeat recorded 26 mentions for D-Wave Quantum and 4 mentions for Astrana Health. Astrana Health's average media sentiment score of 0.63 beat D-Wave Quantum's score of 0.61 indicating that Astrana Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
D-Wave Quantum	9 Very Positive mention(s)	9 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Astrana Health	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Astrana Health has a net margin of 0.86% compared to D-Wave Quantum's net margin of -2,957.23%. Astrana Health's return on equity of 9.22% beat D-Wave Quantum's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
D-Wave Quantum	-2,957.23%	-44.06%	-38.48%
Astrana Health	0.86%	9.22%	3.54%

Astrana Health has higher revenue and earnings than D-Wave Quantum. D-Wave Quantum is trading at a lower price-to-earnings ratio than Astrana Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
D-Wave Quantum	$24.59M	280.72	-$355.06M	-$1.13	N/A
Astrana Health	$3.18B	0.83	$22.49M	$0.61	78.10

D-Wave Quantum presently has a consensus price target of $36.80, indicating a potential upside of 97.20%. Astrana Health has a consensus price target of $45.00, indicating a potential downside of 5.54%. Given D-Wave Quantum's higher probable upside, equities analysts plainly believe D-Wave Quantum is more favorable than Astrana Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
D-Wave Quantum	1 Sell rating(s)	2 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.76
Astrana Health	0 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.78

D-Wave Quantum has a beta of 2.11, meaning that its stock price is 111% more volatile than the broader market. Comparatively, Astrana Health has a beta of 0.89, meaning that its stock price is 11% less volatile than the broader market.

42.5% of D-Wave Quantum shares are owned by institutional investors. Comparatively, 52.8% of Astrana Health shares are owned by institutional investors. 1.3% of D-Wave Quantum shares are owned by insiders. Comparatively, 20.3% of Astrana Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Astrana Health beats D-Wave Quantum on 11 of the 16 factors compared between the two stocks.

How does Astrana Health compare to HealthEquity?

HealthEquity (NASDAQ:HQY) and Astrana Health (NASDAQ:ASTH) are both mid-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, profitability, earnings, media sentiment, dividends, analyst recommendations and valuation.

HealthEquity has higher earnings, but lower revenue than Astrana Health. HealthEquity is trading at a lower price-to-earnings ratio than Astrana Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HealthEquity	$1.31B	6.09	$215.20M	$2.67	35.83
Astrana Health	$3.18B	0.83	$22.49M	$0.61	78.10

In the previous week, HealthEquity had 3 more articles in the media than Astrana Health. MarketBeat recorded 7 mentions for HealthEquity and 4 mentions for Astrana Health. HealthEquity's average media sentiment score of 0.82 beat Astrana Health's score of 0.63 indicating that HealthEquity is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HealthEquity	4 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Astrana Health	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

HealthEquity has a net margin of 17.25% compared to Astrana Health's net margin of 0.86%. HealthEquity's return on equity of 14.75% beat Astrana Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HealthEquity	17.25%	14.75%	9.22%
Astrana Health	0.86%	9.22%	3.54%

99.6% of HealthEquity shares are owned by institutional investors. Comparatively, 52.8% of Astrana Health shares are owned by institutional investors. 1.6% of HealthEquity shares are owned by company insiders. Comparatively, 20.3% of Astrana Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

HealthEquity currently has a consensus target price of $110.57, indicating a potential upside of 15.59%. Astrana Health has a consensus target price of $45.00, indicating a potential downside of 5.54%. Given HealthEquity's higher possible upside, analysts clearly believe HealthEquity is more favorable than Astrana Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HealthEquity	1 Sell rating(s)	1 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.77
Astrana Health	0 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.78

HealthEquity has a beta of 0.21, suggesting that its share price is 79% less volatile than the broader market. Comparatively, Astrana Health has a beta of 0.89, suggesting that its share price is 11% less volatile than the broader market.

Summary

HealthEquity beats Astrana Health on 11 of the 16 factors compared between the two stocks.

How does Astrana Health compare to Stantec?

Astrana Health (NASDAQ:ASTH) and Stantec (NYSE:STN) are both mid-cap business services companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, media sentiment, analyst recommendations, profitability, dividends, valuation and earnings.

52.8% of Astrana Health shares are held by institutional investors. Comparatively, 63.9% of Stantec shares are held by institutional investors. 20.3% of Astrana Health shares are held by company insiders. Comparatively, 0.5% of Stantec shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Stantec has a net margin of 5.92% compared to Astrana Health's net margin of 0.86%. Stantec's return on equity of 19.37% beat Astrana Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Astrana Health	0.86%	9.22%	3.54%
Stantec	5.92%	19.37%	8.03%

Astrana Health currently has a consensus price target of $45.00, indicating a potential downside of 5.54%. Stantec has a consensus price target of $175.00, indicating a potential upside of 154.28%. Given Stantec's higher possible upside, analysts plainly believe Stantec is more favorable than Astrana Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Astrana Health	0 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.78
Stantec	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71

Stantec has higher revenue and earnings than Astrana Health. Stantec is trading at a lower price-to-earnings ratio than Astrana Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Astrana Health	$3.18B	0.83	$22.49M	$0.61	78.10
Stantec	$5.83B	1.34	$343.11M	$3.12	22.06

Astrana Health has a beta of 0.89, indicating that its stock price is 11% less volatile than the broader market. Comparatively, Stantec has a beta of 1, indicating that its stock price has a similar volatility profile to the broader market.

In the previous week, Astrana Health had 1 more articles in the media than Stantec. MarketBeat recorded 4 mentions for Astrana Health and 3 mentions for Stantec. Stantec's average media sentiment score of 1.10 beat Astrana Health's score of 0.63 indicating that Stantec is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Astrana Health	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Stantec	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Stantec beats Astrana Health on 11 of the 16 factors compared between the two stocks.

How does Astrana Health compare to Zillow Group?

Astrana Health (NASDAQ:ASTH) and Zillow Group (NASDAQ:Z) are both mid-cap business services companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, valuation, media sentiment, analyst recommendations, risk, institutional ownership and dividends.

52.8% of Astrana Health shares are owned by institutional investors. Comparatively, 71.0% of Zillow Group shares are owned by institutional investors. 20.3% of Astrana Health shares are owned by company insiders. Comparatively, 23.8% of Zillow Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Astrana Health presently has a consensus price target of $45.00, suggesting a potential downside of 5.54%. Zillow Group has a consensus price target of $74.14, suggesting a potential upside of 130.33%. Given Zillow Group's higher probable upside, analysts plainly believe Zillow Group is more favorable than Astrana Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Astrana Health	0 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.78
Zillow Group	1 Sell rating(s)	6 Hold rating(s)	5 Buy rating(s)	3 Strong Buy rating(s)	2.67

Astrana Health has a beta of 0.89, suggesting that its share price is 11% less volatile than the broader market. Comparatively, Zillow Group has a beta of 1.98, suggesting that its share price is 98% more volatile than the broader market.

Zillow Group has a net margin of 2.27% compared to Astrana Health's net margin of 0.86%. Astrana Health's return on equity of 9.22% beat Zillow Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Astrana Health	0.86%	9.22%	3.54%
Zillow Group	2.27%	1.41%	1.22%

Zillow Group has lower revenue, but higher earnings than Astrana Health. Astrana Health is trading at a lower price-to-earnings ratio than Zillow Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Astrana Health	$3.18B	0.83	$22.49M	$0.61	78.10
Zillow Group	$2.58B	2.85	$23M	$0.25	128.76

In the previous week, Zillow Group had 30 more articles in the media than Astrana Health. MarketBeat recorded 34 mentions for Zillow Group and 4 mentions for Astrana Health. Astrana Health's average media sentiment score of 0.63 beat Zillow Group's score of 0.16 indicating that Astrana Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Astrana Health	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Zillow Group	4 Very Positive mention(s)	2 Positive mention(s)	23 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Zillow Group beats Astrana Health on 10 of the 17 factors compared between the two stocks.

Get Astrana Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ASTH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ASTH vs. The Competition

Export

Metric	Astrana Health	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$2.61B	$6.27B	$7.05B	$12.61B
Dividend Yield	N/A	1.41%	2.68%	8.00%
P/E Ratio	78.10	41.11	27.11	24.26
Price / Sales	0.83	27.89	587.92	117.88
Price / Cash	16.66	19.21	29.22	49.36
Price / Book	3.38	3.70	10.75	6.29
Net Income	$22.49M	$218.81M	$3.58B	$330.66M
7 Day Performance	1.28%	-0.51%	-2.06%	-1.32%
1 Month Performance	23.36%	13.17%	3.32%	-0.64%
1 Year Performance	89.65%	34.26%	26.36%	19.08%

Astrana Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ASTH Astrana Health	2.498 of 5 stars	$47.64 +1.6%	$45.00 -5.5%	+91.3%	$2.61B	$3.18B	78.10	3,000	News Coverage
APLD Applied Digital	3.5251 of 5 stars	$30.71 -8.3%	$70.56 +129.7%	+214.2%	$9.57B	$144.19M	N/A	121	Gap Down
QBTS D-Wave Quantum	3.3871 of 5 stars	$21.03 -6.8%	$36.80 +75.0%	+26.1%	$8.35B	$24.59M	N/A	3
HQY HealthEquity	3.8067 of 5 stars	$96.98 +0.4%	$110.57 +14.0%	+1.2%	$8.07B	$1.31B	36.32	2,814	Positive News
STN Stantec	4.8665 of 5 stars	$68.73 -2.8%	$175.00 +154.6%	-37.7%	$8.01B	$5.83B	22.03	34,000

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ASTH) was last updated on 7/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Astrana Health (ASTH) Competitors

ASTH vs. APLD, QBTS, HQY, STN, and Z

How does Astrana Health compare to Applied Digital?

Summary

How does Astrana Health compare to D-Wave Quantum?

Summary

How does Astrana Health compare to HealthEquity?

Summary

How does Astrana Health compare to Stantec?

Summary

How does Astrana Health compare to Zillow Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ASTH vs. The Competition

Astrana Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Astrana Health (ASTH) Competitors

ASTH vs. APLD, QBTS, HQY, STN, and Z

How does Astrana Health compare to Applied Digital?

Does the media refer more to ASTH or APLD?

Is ASTH or APLD more profitable?

Which has more volatility and risk, ASTH or APLD?

Do analysts recommend ASTH or APLD?

Do institutionals and insiders hold more shares of ASTH or APLD?

Which has stronger valuation and earnings, ASTH or APLD?

Summary

How does Astrana Health compare to D-Wave Quantum?

Does the media prefer QBTS or ASTH?

Is QBTS or ASTH more profitable?

Which has stronger valuation & earnings, QBTS or ASTH?

Do analysts prefer QBTS or ASTH?

Which has more risk & volatility, QBTS or ASTH?

Do institutionals & insiders believe in QBTS or ASTH?

Summary

How does Astrana Health compare to HealthEquity?

Which has better earnings & valuation, HQY or ASTH?

Does the media prefer HQY or ASTH?

Is HQY or ASTH more profitable?

Do institutionals & insiders believe in HQY or ASTH?

Do analysts recommend HQY or ASTH?

Which has more volatility & risk, HQY or ASTH?

Summary

How does Astrana Health compare to Stantec?

Do institutionals & insiders have more ownership in ASTH or STN?

Is ASTH or STN more profitable?

Do analysts rate ASTH or STN?

Which has better earnings and valuation, ASTH or STN?

Which has more volatility and risk, ASTH or STN?

Does the media refer more to ASTH or STN?

Summary

How does Astrana Health compare to Zillow Group?

Do institutionals and insiders have more ownership in ASTH or Z?

Do analysts rate ASTH or Z?

Which has more volatility & risk, ASTH or Z?

Is ASTH or Z more profitable?

Which has stronger valuation and earnings, ASTH or Z?

Does the media favor ASTH or Z?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ASTH vs. The Competition

Astrana Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools